Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human iPSC application in Alzheimer’s disease and Tau-related neurodegenerative diseases
Julia TCW
Neuroscience Letters (2019) Vol. 699, pp. 31-40
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Genetic architecture of Alzheimer's disease
Sarah M. Neuner, Julia TCW, Alison Goate
Neurobiology of Disease (2020) Vol. 143, pp. 104976-104976
Open Access | Times Cited: 99
The triad of nanotechnology, cell signalling, and scaffold implantation for the successful repair of damaged organs: An overview on soft-tissue engineering
Parinaz Abdollahiyan, Fatemeh Oroojalian, Ahad Mokhtarzadeh
Journal of Controlled Release (2021) Vol. 332, pp. 460-492
Closed Access | Times Cited: 74
Human iPSC-Derived Neural Models for Studying Alzheimer’s Disease: from Neural Stem Cells to Cerebral Organoids
Martin Barák, Veronika Fedorová, Veronika Pospíšilová, et al.
Stem Cell Reviews and Reports (2022) Vol. 18, Iss. 2, pp. 792-820
Open Access | Times Cited: 56
Revolutionizing Disease Modeling: The Emergence of Organoids in Cellular Systems
Rita Silva-Pedrosa, António J. Salgado, Pedro Eduardo Ferreira
Cells (2023) Vol. 12, Iss. 6, pp. 930-930
Open Access | Times Cited: 34
Metabolic perspective of astrocyte dysfunction in Alzheimer's disease and type 2 diabetes brains
Zheng Shen, Zhengyang Li, Mengting Yu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114206-114206
Open Access | Times Cited: 31
The Amyloid-Beta Clearance: From Molecular Targets to Glial and Neural Cells
Wenjun Cai, Tong Wu, Ning Chen
Biomolecules (2023) Vol. 13, Iss. 2, pp. 313-313
Open Access | Times Cited: 27
Alzheimer’s Disease Treatment: The Search for a Breakthrough
Allison B. Reiss, Dalia Muhieddine, Berlin Jacob, et al.
Medicina (2023) Vol. 59, Iss. 6, pp. 1084-1084
Open Access | Times Cited: 16
Low glucose induced Alzheimer's disease‐like biochemical changes in human induced pluripotent stem cell‐derived neurons is due to dysregulated O‐GlcNAcylation
Chia‐Wei Huang, Nicholas C. Rust, Hsueh‐Fu Wu, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 11, pp. 4872-4885
Open Access | Times Cited: 12
Human induced pluripotent stem cell models for Alzheimer’s disease research: a bibliometric analysis
Yuning Sun, Zhilong Liu, Zongbo Zhang, et al.
Frontiers in Human Neuroscience (2025) Vol. 19
Open Access
Polyaniline-polycaprolactone fibers for neural applications: Electroconductivity enhanced by pseudo-doping
Fábio F. F. Garrudo, Paiyz E. Mikael, Carlos A. V. Rodrigues, et al.
Materials Science and Engineering C (2020) Vol. 120, pp. 111680-111680
Closed Access | Times Cited: 30
Uncovering specificity of endogenous TAU aggregation in a human iPSC-neuron TAU seeding model
Justine D. Manos, Christina N. Preiss, Nandini Venkat, et al.
iScience (2021) Vol. 25, Iss. 1, pp. 103658-103658
Open Access | Times Cited: 22
Altered O-GlcNAcylation and mitochondrial dysfunction, a molecular link between brain glucose dysregulation and sporadic Alzheimer’s disease
Gerald W. Hart, Chia‐Wei Huang, NicholasC Rust, et al.
Neural Regeneration Research (2022) Vol. 18, Iss. 4, pp. 779-779
Open Access | Times Cited: 15
The Role of Chronic Inflammatory Bone and Joint Disorders in the Pathogenesis and Progression of Alzheimer's Disease
Robert A. Culibrk, Mariah S. Hahn
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 21
Electrical stimulation of neural-differentiating iPSCs on novel coaxial electroconductive nanofibers
Fábio F. F. Garrudo, Diogo E.S. Nogueira, Carlos A. V. Rodrigues, et al.
Biomaterials Science (2021) Vol. 9, Iss. 15, pp. 5359-5382
Closed Access | Times Cited: 20
Studying Microtubule Dynamics in Human Neurons: Two-Dimensional Microtubule Tracing and Kymographs in iPSC- and SH-SY5Y-Derived Neurons for Tau Research
Nadine Allroggen, H. D. Breuer, Sarah Bachmann, et al.
Methods in molecular biology (2024), pp. 561-580
Closed Access | Times Cited: 2
Unlocking the therapeutic potential: odyssey of induced pluripotent stem cells (iPSC) in precision cell therapies
Popat Mohite, Roshan Dave, Arati Budhar, et al.
International Journal of Surgery (2024) Vol. 110, Iss. 10, pp. 6432-6455
Open Access | Times Cited: 2
Advances in Genetic and Molecular Understanding of Alzheimer’s Disease
Laura Ibáñez, Carlos Cruchaga, María Victoria Fernández
Genes (2021) Vol. 12, Iss. 8, pp. 1247-1247
Open Access | Times Cited: 15
Prospects of Directly Reprogrammed Adult Human Neurons for Neurodegenerative Disease Modeling and Drug Discovery: iN vs. iPSCs Models
Ying Zhang, Xinyang Xie, Jiangnan Hu, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 15
Mutations in human DNA methyltransferase DNMT1 induce specific genome-wide epigenomic and transcriptomic changes in neurodevelopment
Kasey Davis, Pingping Qu, Shining Ma, et al.
Human Molecular Genetics (2023) Vol. 32, Iss. 21, pp. 3105-3120
Open Access | Times Cited: 5
Human-Induced Pluripotent Stem Cells and Herbal Small-Molecule Drugs for Treatment of Alzheimer’s Disease
Liwei Wu, Sheng‐Tzung Tsai, Tzyy‐Wen Chiou, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1327-1327
Open Access | Times Cited: 13
Deconstructing Alzheimer’s Disease: How to Bridge the Gap between Experimental Models and the Human Pathology?
Anaïs Vignon, Lucie Salvador-Prince, Sylvain Lehmann, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8769-8769
Open Access | Times Cited: 12
Neurodegeneration in a dish: advancing human stem-cell-based models of Alzheimer’s disease
Julien Klimmt, Angelika Dannert, Dominik Paquet
Current Opinion in Neurobiology (2020) Vol. 61, pp. 96-104
Closed Access | Times Cited: 12
Transcription Factor-Mediated Generation of Dopaminergic Neurons from Human iPSCs—A Comparison of Methods
Kirstin O. McDonald, Nikita M. A. Lyons, Luca K. C. Gray, et al.
Cells (2024) Vol. 13, Iss. 12, pp. 1016-1016
Open Access | Times Cited: 1
Primary cortical cell tri-culture to study effects of amyloid-β on microglia function and neuroinflammatory response
Hyehyun Kim, Bryan Le, Noah Goshi, et al.
Journal of Alzheimer s Disease (2024)
Closed Access | Times Cited: 1
Alzheimer’s Disease Treated with Autologous and Allogeneic TelomerasePositive Stem Cells
Warren Young, Mark O Speight
Stem Cell & Regenerative Medicine (2021) Vol. 5, Iss. 1
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top